Kasumi-3-Luc-mCh-Puro: Human Leukemia (AML)

Kasumi-3-Luc-mCh-Puro: Human Leukemia (AML) Growth Curve Chart

(actual study data; representative)

Parameter Information
Strain SCID Beige
Implant Type Cells
Implant Location IV
Time to Staging ~20 days
Time to Evaluation Size (1.0E+08) 38 days
Td 6 days

(The above parameters are from one study. For further information on this cell line and other parameters, including different strains, vendors, implant type and location and/or standards of care, please contact Covance.)

Histotype: Leukemia [AML]

Tumor Line: Human

REF# 9085